PROCEPT BioRobotics (PRCT) Research & Development (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Research & Development for 7 consecutive years, with $20.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 14.0% year-over-year to $20.1 million in Q2 2026; TTM through Jun 2026 was $78.8 million, a 19.87% increase from a year earlier, with the FY2025 full-year figure at $71.3 million, up 14.41% from the prior year.
• Research & Development was $20.1 million for Q2 2026 at PROCEPT BioRobotics, down from $21.5 million in the prior quarter.
• Over five years, Research & Development peaked at $21.5 million in Q1 2026 and troughed at $5.0 million in Q1 2022.
• A 5-year average of $14.0 million and a median of $14.8 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 114.27% in 2023 and climbed 0.75% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $9.7 million in 2022, then jumped by 49.72% to $14.5 million in 2023, then advanced by 3.93% to $15.1 million in 2024, then climbed by 26.48% to $19.1 million in 2025, then advanced by 5.48% to $20.1 million in 2026.
• The last three Research & Development figures came in at $20.1 million (Q2 2026), $21.5 million (Q1 2026), and $19.1 million (Q4 2025), per Business Quant data.